ES
MDGSW

Equitec Specialists’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History

Equitec Specialists’s Portfolio MDGSW Stock Details MDGSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75,000
Closed -$65K – 142
2021
Q1 		$65K Hold
75,000
– – 0.01% 154
2020
Q4 		$29K Buy
75,000
+44,960
+150% +$15.2K ﹤0.01% 188
2020
Q3 		$5K Hold
30,040
– – ﹤0.01% 160
2020
Q2 		$6K Buy
+30,040
New +$10.3K ﹤0.01% 135

Other funds holding MDGSW

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return

Equitec Specialists's MDGSW Position: Q2 2021 in Review

Equitec Specialists sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q2 2021, closing a stake of 75,000 shares — an estimated $65K sold.

Equitec Specialists first reported a position in MDGSW in Q2 2020 and held it in 4 quarters. The position peaked at $65K in Q1 2021. 5 funds tracked by Wall St. Rank hold MDGSW as of Q2 2021.

  • Equitec Specialists reported no remaining Medigus Ltd. Series C Warrant position as of Q2 2021 after selling out during the quarter.
  • Equitec Specialists sold 75,000 Medigus Ltd. Series C Warrant shares in Q2 2021, an estimated $65K.
  • Equitec Specialists first reported a position in Medigus Ltd. Series C Warrant in Q2 2020 and held it in 4 quarters.
  • Equitec Specialists's Medigus Ltd. Series C Warrant position peaked at $65K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q2 2021.

Based on Equitec Specialists's 13F filing for Q2 2021, filed 20 Jul 2021.